Venue: HORIBA Symposium Hall, International Science Innovation Building, Kyoto University, Kyoto, Japan  |  Date: April 12-14, 2027
medicinalchemistryconference
Conference Opens In
--Days
:
--Hours
:
--Mins
:
--Secs
Abstract Deadline: November 30, 2026
3
Conference Days
10+
Scientific Sessions
8
Research Themes
50+
Invited Speakers
200+
Expected Delegates

International Conference and Exhibition on Progressive Medicinal Chemistry

Welcome to the International Conference and Exhibition on Progressive Medicinal Chemistry (ProMediCon 2027), to be held on April 12–14, 2027, at the HORIBA Symposium Hall, International Science Innovation Building, Kyoto University, Kyoto, Japan.

ProMediCon 2027, jointly organized by the India–Japan Society for Science, Technology and Education (IJSTE), the Chemical Biology Society of India (CBSI), and SciVerse Global, will bring together leading researchers, healthcare professionals, industry experts, and young scientists from around the world to share knowledge, discuss emerging trends, and foster collaborations in medicine, healthcare, and life sciences. The conference provides a unique platform to showcase innovative research, exchange ideas, and address global healthcare challenges. Hosted at the prestigious Kyoto University during the beautiful Sakura (Cherry Blossom) season, the conference offers an inspiring environment that combines scientific excellence, cultural heritage, and international networking.

The conference will showcase the latest advancements and emerging trends in the broad field of Medicinal Chemistry. The scientific programme will cover a wide range of key topics, including Drug Discovery and Development, Pharmaceutical Chemistry, Chemical Biology, Bioorganic Chemistry, Computational Drug Design, Molecular Design, Pharmacology, Medicinal Natural Products, ADME and Toxicology, Structure-Based Drug Design, Pharmaceutical Sciences, Precision Medicine, Healthcare Innovation, and Translational Therapeutics. This diverse scope aims to foster interdisciplinary collaboration, encourage the exchange of innovative ideas, and accelerate progress in the development of next-generation therapeutics for global healthcare challenges.

We warmly invite you to join us in Kyoto, Japan, from April 12–14, 2027, and contribute to shaping the future of medicine and healthcare through collaboration, innovation, and scientific excellence.

We look forward to welcoming you to ProMediCon 2027.

Conference Chairs

K_S_Rangappa

K. S. Rangappa

DSc, FRSC, FNASc, FBRS, FTWAS

NASI Distinguished Chair Professor
Former Vice-Chancellor, University of Mysore, India
Ambassador, Hokkaido University, Japan

Hiroshi Sugiyama

Hiroshi Sugiyama

Emeritus Professor

Institute for Integrated Cell-Material Sciences (iCeMS)
Kyoto University, Japan

Conference Co-Chairs

Ganesh Pandian, Ph.D.

Ganesh Pandian

Director

IN-CBI, WPI-iCeMS
Kyoto University, Japan

Sidda Basavegowda, Ph.D.

Sidda Basavegowda

Associate Professor

Faculty of Health Sciences and Technology
Hokkaido University, Japan.

Co- Organizers Organizing Partner

India Japan Society for Science, Education & Technology

India Japan Society for Science, Education & Technology

Chemical Biology Society of India

Chemical Biology Society of India

Sciverse Global LLC

Sciverse Global LLC

Medicinal Chemistry Conference Themes

Eight Pillars of
Modern Drug Discovery

PROMEDICON 2027 spans the full spectrum of contemporary medicinal chemistry and pharmaceutical science.

🧠

Intelligent Drug Discovery

Harnessing AI, quantum computing, and digital twins to transform molecular design at unprecedented scale.

AI-Driven Generative Quantum
🧬

Advanced Therapeutics

mRNA platforms, antibody-drug conjugates, biologics, and microbiome-based therapeutic innovations.

mRNA ADCs Biologics
🧪

Molecular Innovation

PROTACs, targeted protein degradation, polypharmacology, and advanced synthesis strategies.

PROTACs FBDD Synthesis
🏥

Precision Medicine

Immuno-oncology, neurodegeneration, rare disease drug discovery, and personalized therapeutics.

Oncology Neuro Rare Diseases
🚚

Drug Delivery & Translational

Nanomedicine, blood-brain barrier strategies, PK/PD & ADME, and lab-to-market translation.

Nano BBB ADME
☢️

Radiopharma & Theranostics

Radioligand therapy, molecular imaging, and the integration of diagnosis with therapy.

RLT Imaging Theranostics
🌱

Sustainable Chemistry

Green and circular chemistry principles, natural products, and eco-friendly pharmaceutical processes.

Green Circular Natural
🤖

Future Technologies

Autonomous laboratories, high-throughput experimentation, robotics, and AI-driven process optimization.

Robotics HTE Automation

Medicinal Chemistry and Drug Discovery Conference Program

Three Days of
Transformative Science

A comprehensive agenda spanning AI-driven discovery, translational medicine, and sustainable pharmaceutical futures.

🧠

Intelligent Discovery & Molecular Design

FOCUS: AI · Data Science · Molecular Design · Chemical Biology

⭐ Plenary Lecture 1

AI, Data Science & the Future of Drug Discovery

AI-Driven Drug Discovery Quantum Computing Digital Twins AI Ethics
Session I

AI, Data Science & Digital Drug Discovery

  • Generative Molecular Design & Predictive Modeling
  • Big Data & Real-World Evidence
  • Automation, Robotics & Autonomous Labs
  • Data Integrity & Open Science
Session II

Medicinal Chemistry & Molecular Design

  • Covalent & Fragment-Based Drug Design
  • PROTACs & Targeted Protein Degradation
  • Polypharmacology & Multi-Target Strategies
  • Continuous Flow & Advanced Synthesis
Session III

Chemical Biology & Target Identification

  • Chemical Biology & Functional Genomics
  • CRISPR & Gene Editing Technologies
  • Biosensors & Diagnostic Platforms
  • Organoids & Advanced Disease Models
Evening Event

Poster Session I + Industry Exhibition

  • Oral & Poster Presentations
  • Industry Partner Showcases
  • Networking Reception
  • Lab-to-Market Pitches
🧬

Translational Medicine & Advanced Therapeutics

FOCUS: Biologics · Precision Medicine · Drug Delivery · Theranostics

⭐ Plenary Lecture 2

Precision Medicine & Next-Generation Therapeutics

Personalized Medicine Immunotherapy Rare Diseases
Session IV

Advanced Therapeutics & Biopharmaceuticals

  • mRNA Therapeutics & Vaccine Innovation
  • Antibody-Drug Conjugates (ADCs)
  • Protein Engineering & Biologics
  • Microbiome-Based Therapeutics
Session V

Precision Medicine & Disease Applications

  • Immuno-oncology & Targeted Cancer Therapies
  • Neurodegenerative Disease Drug Discovery
  • Rare & Orphan Diseases
  • Pandemic Preparedness
Session VI

Drug Delivery, PK/PD & Translational Science

  • Smart Nanomedicine & Targeted Delivery
  • Blood-Brain Barrier Strategies
  • PK/PD, ADME & Drug Safety
  • Lab-to-Market Translation
Session VII

Radiopharmaceuticals & Theranostics

  • Radioligand Therapy
  • Molecular Imaging & Spectroscopy
  • Theranostics: Diagnosis + Therapy Integration
🎯   Poster Session II + Panel Discussion  — Theme: Bridging Academia and Industry in Drug Development
🚀

Future Frontiers, Sustainability & Global Impact

FOCUS: Green Chemistry · Automation · Regulation · Innovation Ecosystems

⭐ Plenary Lecture 3

Sustainable & Future Pharmaceutical Sciences

Green Chemistry Circular Pharma Net-Zero Goals
Session VIII

Sustainable & Green Medicinal Chemistry

  • Green & Circular Chemistry
  • Natural Products & Bio-inspired Drug Discovery
  • Electrochemical & Photoelectrochemical Systems
Session IX

Emerging Technologies & Automation

  • Autonomous Labs & Robotics
  • High-Throughput Experimentation
  • AI-Driven Process Optimization
Session X

Industry, Regulation & Innovation Ecosystem

  • Regulatory Science & Global Approvals
  • Startup Ecosystems & Technology Transfer
  • Process Innovation & Scale-Up
💡 Grand Debate

"Will AI Replace the Medicinal Chemist?"

  • AI in Drug Discovery — Promise & Peril
  • Ethics of Machine-Driven Science
  • Human–Machine Collaboration Models
🏆   Awards & Closing Ceremony  — Best Oral & Poster Awards · Young Scientist Recognition

Who Should Attend International Conference on Medicinal Chemistry

A Conference for
Every Pioneer

PROMEDICON 2027 welcomes the entire drug discovery ecosystem — from bench to boardroom.

🧪

Academic & Research Scientists

Professors, PhD scholars, and computational scientists in medicinal chemistry, chemical biology, and pharmaceutical sciences.

💊

Pharma & Biotech Professionals

R&D leaders and clinical researchers advancing small molecules, biologics, and next-generation therapeutics.

🤖

AI & Computational Experts

ML researchers, data scientists, and automation engineers applying machine learning to drug discovery.

🏥

Clinicians & Translational Scientists

Oncologists, neurologists, and clinical investigators driving precision medicine from lab to clinic.

🧬

Advanced Therapeutics Researchers

Experts in gene therapy, mRNA platforms, immunotherapy, and targeted protein degradation.

⚙️

Process & Green Chemistry Experts

Specialists in sustainable chemistry, catalysis, and scalable pharmaceutical manufacturing.

📊

Regulatory & Policy Leaders

Specialists in regulatory science, ethics, and global drug approval navigating complex compliance landscapes.

🚀

Startups & Investors

Entrepreneurs, venture capitalists, and innovation leaders driving the next wave of biotech breakthroughs.

🎓

Students & Early-Career Researchers

MSc and PhD candidates seeking mentorship, collaboration, and career-defining scientific opportunities.

Promedicon 2027 Venue & Location

Where Science Meets
Tradition

⛩️

HORIBA Symposium Hall
International Science Innovation Building
Kyoto University

Kyoto, Japan · April 12-14, 2027

UNESCO Heritage City Top 100 Global University Nobel Prize Legacy

Join the Top Medicinal Chemistry Conference in Asia

Register Your Interest

Secure your place at the premier global gathering of medicinal chemistry and drug discovery innovation. Early-bird rates available for a limited time.

✓

Success

Your registration has been submitted successfully.

✓

Success

Your registration has been submitted successfully.

PROMEDICON 2027 FAQs

What is PROMEDICON 2027?
PROMEDICON 2027 (International Conference on Progressive Medicinal Chemistry) is a premier international conference features breakthroughs in drug discovery, medicinal chemistry, chemical biology, artificial intelligence in drug design, precision medicine, pharmaceutical sciences, chemical biology, AI-driven drug discovery, and translational therapeutics. Promedicon 2027 conference is organized by the Chemical Biology Society and India Japan Society for Science, Education & Technology. It brings together Nobel Laurates, leading researchers, pharmaceutical companies, biotechnology innovators, clinicians, and computational scientists from around the world.
Who will attend PROMEDICON 2027?
Promedicon 2027 is one of most prestigious and internationally recognised conferences in Medicinal Chemistry and Drug Discovery attended by researchers from top universities and pharmaceutical companies including Nobel Laurates, professors, pharmaceutical companies, biotechnology innovators, clinicians, scientists, early-career researchers, postdocs and PHD students. The conference also includes participation from pharmaceutical companies, Biotechnology companies, CROs, CDMOs, AI Drug Discovery companies, Healthcare technology companies, Startups and Investors. This multidisciplinary audience reflects the conference's emphasis on connecting research with industrial translation which makes the Promedicon 2027 the best medicinal chemistry and drug discovery conference for academic and industry collaboration opportunities.
I want to submit an abstract—has the deadline passed?
Not at all! We are pleased to confirm that our abstract submission deadline hasn't passed yet—in fact, we have extended the window to accommodate late-breaking research. This makes PROMEDICON one of the Upcoming Medicinal chemistry and drug discovery conferences where you can still participate actively. Our abstract deadlines in the next 3 months (final cutoff: May 15, 2027) give you ample time to prepare and submit your work. We are actively accepting submissions across all tracks, so if you are looking for conferences that are still accepting abstracts in Medicinal chemistry and drug discovery, PROMEDICON is your best bet. Early submissions also get priority consideration for oral presentation slots.
What makes PROMEDICON 2027 the best medicinal chemistry conference for networking with pharmaceutical researchers?
Happening in the year 2027, PROMEDICON is considered one of the best Medicinal chemistry and drug discovery conferences to attend because it deliberately engineers networking at every level. Beyond traditional poster sessions, we host "Pharma-Connect Roundtables" where attendees share tables with R&D heads from top 20 global pharmaceutical companies. Our dedicated industry-academia lounge, daily "Collaboration Happy Hours," and a customized meeting-scheduler app ensure you spend less time guessing and more time networking with pharma/biotech professionals, and presenting research in a focused setting. This is why PROMEDICON is ranked among top 5 and top 10 Medicinal chemistry and drug discovery conferences based on speaker quality and attendance—and consistently receives attendee ratings higher than 4.5 across all previous editions.
What advanced workshops and training sessions does PROMEDICON offer?
PROMEDICON 2027 is widely recognized as the conference that offers the most advanced drug discovery workshops among all Upcoming chemistry conferences with abstract deadlines in the next 3 months. Our workshop program includes hands-on sessions on AI-driven de novo molecule generation, cryo-EM for structure-based design, automated high-throughput screening robotics, and real-world case studies in PROTAC optimization. We also host Workshops and symposia on latest trends in medicinal chemistry such as RNA-targeting small molecules, degrader technologies, and covalent kinase inhibitors. These are led by industry trainers from top biotech firms, making this a top-tier conference for learning about new computational drug design methods and experimental techniques.
When and where will PROMEDICON 2027 be held?
Promedicon 2027 (International Conference on Progressive Medicinal Chemistry) will be held in Kyoto University, Japan on April 12–14, 2027. HORIBA Symposium Hall, International Science Innovation Building (iSIS), Kyoto University, Kyoto, Japan. This major medicinal chemistry and drug discovery conference takes place during Japan's famous Sakura (Cherry Blossom) season, offering an exceptional scientific and cultural experience which makes it the best international medicinal chemistry and drug discovery conference to attend this year.
What topics will be covered in PROMEDICON 2027 that make it worth attending?
This high-quality, internationally recognised conference on Medicinal Chemistry and Drug Discovery focuses on high-level, discussion-driven format and covers major topics such as Medicinal Chemistry, Drug Discovery & Development, Chemical Biology, Pharmaceutical Sciences, AI & Machine Learning in Drug Discovery, Computational Drug Design, Precision Medicine, Pharmacology, Molecular Design, ADME & Toxicology, Translational Therapeutics, Immunotherapy, mRNA Therapeutics, PROTACs & targeted protein degradation, Drug Delivery, Green Medicinal Chemistry, Regulatory Science, Covalent drug design, Macrocycles & peptide therapeutics, ADMET optimization, Chem-biology and chemical probes, RNA-targeting small molecules, Cancer drug discovery & oncology chemistry, Antiviral medicinal chemistry, Antimicrobial drug discovery, Central nervous system drug design, HTS, chemical biology, screening, Pharmaceutical sciences & drug delivery, Interface of biology and medicinal chemistry, Analytical tools in pharmaceutical chemistry.
What are the registration fees, and are there travel grants or student funding available?
We are proud to offer one of the most affordable yet high-quality international conferences in this field. Our early-bird academic registration is significantly lower than comparable events, and we provide travel grants, fee waivers or student funding for meritorious students, postdocs, and early-career researchers from low- and middle-income countries. We also have a "Sakura Scholar" program that covers full registration and accommodation for 10 selected young scientists. With the lowest registration fee but still has a reputable proceedings publication, PROMEDICON ensures that cost is never a barrier. This commitment to accessibility, combined with our scientific rigor, makes us one of the best Medicinal chemistry and drug discovery conferences to attend for budget-conscious researchers.
Does PROMEDICON 2027 offer journal publication and proceedings indexing?
Yes. PROMEDICON 2027 is a legitimate conference that partners with leading scientific publishers to ensure all accepted full papers and selected extended abstracts are published in a special conference issue. Does this conference offer journal publication with proceedings indexed in Web of Science and Scopus? Absolutely—we have confirmed indexing partnerships with journals that are Scopus- and Web of Science-listed, ensuring your work gains maximum visibility. Additionally, we publish proceedings in high-impact journals with an impact factor >3.0, making this one of the Best conferences in Medicinal Chemistry in 2027 for researchers who need indexed publications for career advancement.
Why should I attend PROMEDICON 2027 over other conferences in Asia?
PROMEDICON 2027 is consistently listed among the top 10 medicinal chemistry conferences in Asia—and for good reason. It has the strongest research program featuring Top tier best speakers, including multiple Nobel Laureates, ACS Award winners, and R&D chiefs from major pharma. Sponsored by American Chemical Society or Royal Society of Chemistry in partnership with our local organizers, this conference has the highest reputation globally and is attended by top university professors from MIT, Cambridge, Oxford, Tokyo, Kyoto, and the National Institutes of Health. For career-focused attendees, this is one of the Best medicinal chemistry conferences for career development and job opportunities, with a dedicated career fair and mentoring sessions. If you are looking for best conferences for pharmaceutical chemists or best medicinal chemistry conferences for academic researchers in 2027, PROMEDICON delivers unmatched scientific depth, cultural richness in Kyoto during Sakura season, and lasting professional connections—making it a clear Recommendation for medicinal chemistry conferences that focus on small molecule drug design and translational science.

Disclaimer & Scam Alert

The PROMEDICON 2027 Organizing Committee does not authorize any third party to contact participants regarding registration, accommodation, visa services, or attendee lists. Please rely only on information available on the official PROMEDICON 2027 website and communications sent directly by the Organizing Committee. If you receive any suspicious email, phone call, or payment request claiming to represent PROMEDICON 2027, please do not respond or make any payment. Instead, contact the Conference Secretariat for verification. The Organizing Committee is not responsible for any loss or damage resulting from communications or transactions with unauthorized third parties.